Drug for babies with SMA to cost $US2 mil

By John Miller and Caroline Humer
Updated May 25 2019 - 6:43am, first published 6:39am
Novartis' one-time gene therapy drug for babies is the most expensive in the world at $US2 million.
Novartis' one-time gene therapy drug for babies is the most expensive in the world at $US2 million.

Swiss drugmaker Novartis has won US approval for its gene therapy Zolgensma for spinal muscular atrophy and has priced the one-time treatment at a record $US2.125 million ($A3 million).

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options

Get the latest Goulburn news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.